Besides, researches in neuroblastoma and colorectal cancer showed that Myc could positively regulate CDC6 (38) and COL17A1 (39) expression, respectively, suggesting that these two signature genes may be the downstream target of PVT1-MYC duet in pancreatic cancer. Here, MYC is linked to neuroblastoma.